Fortress Biotech, Inc. (FBIO) Downgraded by ValuEngine to Sell

Fortress Biotech, Inc. (FBIO) Downgraded by ValuEngine to Sell


FBIO has been the subject of a number of other research reports. HC Wainwright set a $11.00 price objective on shares of Fortress Biotech and gave the stock a buy rating in a research report on Tuesday, July 11th.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога